Clinical Trials Logo

Thoracic Aortic Dissection clinical trials

View clinical trials related to Thoracic Aortic Dissection.

Filter by:

NCT ID: NCT06336213 Recruiting - Clinical trials for Thoracic Aortic Aneurysm

Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.

NCT ID: NCT06270537 Recruiting - Clinical trials for Thoracic Aortic Dissection

Post-market Clinical Trial of the Dominus® Stent-Graft

DominusPMCF
Start date: October 24, 2023
Phase:
Study type: Observational

Real-world clinical trial evidence post-market, evaluating the safety and efficacy of the Dominus® StentGraft Endoprosthesis in treating thoracic aortic diseases, following the Instructions for Use

NCT ID: NCT05771831 Completed - Clinical trials for Thoracic Aortic Dissection

Thrombosomes® in Acute Thoracic Aortic Dissections

TTAD
Start date: March 15, 2023
Phase: Phase 2
Study type: Interventional

The hypothesis is that administration of Thrombosomes® (TBX®) as hemostatic support when terminating the cardiopulmonary bypass (CPB) in patients undergoing emergency surgery for acute thoracic aortic dissection (aTAD) is safe and least as effective when compared to standard Platelet Concentrates (stPC).

NCT ID: NCT05639400 Recruiting - Aortic Aneurysm Clinical Trials

Thoraflex Hybrid and Relay Extension Post-Approval Study

EXTEND
Start date: March 17, 2023
Phase:
Study type: Observational

The goal of this observational study is to evaluate the Thoraflex Hybrid device alone and in combination with the RelayPro NBS stent-graft in the treatment of aortic disease affecting the aortic arch and descending aorta with or without involvement of the ascending aorta. Patients who undergo treatment with the Thoraflex Hybrid device with or without extension with a RelayPro NBS stent-graft will be eligible for enrolment and study activities and follow-up regime will follow standard care at each participating site. Participant involvement in the study will last for a total of 10 years from the point at which the Thoraflex Hybrid device is placed.

NCT ID: NCT05610462 Active, not recruiting - Clinical trials for Thoracic Aortic Dissection

Trial of Exercise in Aortic Dissection Survivors

Start date: January 28, 2023
Phase: N/A
Study type: Interventional

The primary objective of this study is to test the safety and mental health benefits of a guided exercise program for people who survived an acute aortic dissection. This study is designed to answer several questions: 1. Can supervised exercise improve confidence and mental health in dissection survivors?; 2. How safe are different types of exercise for people who are living with severe aortic disease?; 3. Can tests be developed to determine rational and safe limits to guide exercise recommendations for individual patients?; 4. Does the blood pressure response to exercise predict risks for aortic enlargement or dissection in unique ways that other tests may not detect? The long-term goal of this research is to develop new guidelines for exercise and daily activities that promote the safety and well-being of all TAD patients. All participants will be required to: - Complete online questionnaires (demographic survey, 2009 Behavioral Risk Factor Surveillance Survey, the Patient-Reported Outcomes Measurement Information System 29 (PROMIS-29) v2.0 profile questionnaire) - Exercise (>150 minutes/week) - Receive all usual clinically indicated care, including diagnostic tests and medications. Recommendations for tests or interventions will not change based on the assigned study arm. Participants who are randomized to guided exercise group will undergo initial training that consists of: one video demonstration, one exercise training session or group session, one follow up home visit, and virtual check-ins. Participants who are randomized to usual care will attend routine clinic visits but will not receive any teaching or supervision and will not participate in any in-person or virtual exercise sessions. Instead, they will receive standardized counseling about exercise, including an exercise pamphlet that is given to all TAD patients.

NCT ID: NCT05414318 Completed - Clinical trials for Thoracic Aortic Aneurysm

CTAG Dissection/Trauma Post Marketing Surveillance Japan

Start date: January 5, 2016
Phase:
Study type: Observational

Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis

NCT ID: NCT05309707 Recruiting - Clinical trials for Cardiovascular Diseases

ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

The ENDOBARC-S post-market clinical follow-up study is undertaken to evaluate the prevention of death related to aortic arch pathologies when treated by branch stent graft systems (Nexus stent-graft system®, Relay Branch® or Zenith arch branch graft®), with proximal landing at zone 0. The secondary objective is to evaluate the safety and clinical performance of the studied devices.

NCT ID: NCT05155956 Enrolling by invitation - Clinical trials for Thoracic Aortic Aneurysm

Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System

CHaMP
Start date: December 15, 2021
Phase:
Study type: Observational

This is an observational cohort study addressing the incidence of cerebral microemboli and alterations of cerebral hemodynamic physiology of the Relay®Branch thoracic stent-graft system.

NCT ID: NCT04267055 Active, not recruiting - Clinical trials for Thoracic Aortic Dissection

DISSECT-N Post Market Data Collection Registry

DISSECT-N
Start date: June 25, 2020
Phase:
Study type: Observational [Patient Registry]

DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of thoracic aortic dissections in real world practice.

NCT ID: NCT03767777 Enrolling by invitation - Clinical trials for Thoracic Aortic Dissection

Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY(PATENCY)

Start date: February 1, 2019
Phase: N/A
Study type: Interventional

A prospective, multi-centre, objective performance criteria clinical trial to evaluate the safety and efficacy of Artery Stent Graft System manufactured by Lifetech Scientific (Shenzhen) Co., LTD. for the thoracic aortic dissection involving the aortic arch.